NASC Can B Corp
Wholesale-Drugs, Proprietaries & Druggists' Sundries · OTC · SEC CIK 1509957 · Fiscal year ends 12/31
Financial factors as of 2023-12-31 (2023Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY-67.8%
TTM net income YoY34.8%
TTM EPS YoY81.6%
Revenue 3-yr CAGR8.0%
Net income 3-yr CAGR—
Margins
Gross margin16.6%
Operating margin-347.3%
Net margin-451.7%
FCF margin-61.2%
EBITDA margin-282.9%
Returns
ROE-2,317.5%
ROA-75.8%
ROIC (approx.)-1,613.4%
Asset turnover0.17x
Leverage & solvency
Liabilities / assets118.3%
Debt / equity—
Current ratio0.45x
Interest coverage-2.98x
Cash quality & payout
Operating cash flow / net income0.13x
Accruals ratio-65.7%
Payout ratio—
Capex / revenue0.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2024Q32024-09-30 | 2024Q22024-06-30 | 2024Q12024-03-31 | 2023Q4*2023-12-31 | 2023Q32023-09-30 | 2023Q22023-06-30 | 2023Q12023-03-31 | 2022Q4*2022-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $15,269 | $272,287 | $369,096 | $376,889 | $418,957 | $420,593 | $939,305 | $666,073 |
| Cost of revenue | $415,816 | $665,471 | $1.19M | -$897,602 | $1.24M | $934,425 | $524,577 | $820,817 |
| Gross profit | -$400,547 | -$393,184 | -$824,065 | $1.27M | -$816,690 | -$513,832 | $414,728 | -$154,744 |
| SG&A expense | $2.43M | $1.17M | $1.69M | — | $2.76M | $1.31M | $1.85M | — |
| Operating income | -$2.83M | -$1.57M | -$5.65M | -$651,715 | -$3.58M | -$1.82M | -$1.43M | -$2.59M |
| Interest expense | $430,173 | $463,366 | $506,182 | $1.18M | $585,417 | $416,415 | $333,967 | $242,736 |
| Pretax income | -$3.26M | -$2.03M | -$6.16M | -$1.81M | -$4.17M | -$2.03M | -$1.73M | -$2.90M |
| Income tax | — | — | — | $0 | $0 | $0 | $9,596 | — |
| Net income | -$3.26M | -$2.03M | -$6.16M | -$1.81M | -$4.17M | -$2.03M | -$1.74M | -$2.90M |
| EBITDA | -$2.83M | -$1.54M | -$5.34M | -$304,681 | -$3.23M | -$1.48M | -$1.09M | -$2.24M |
| EPS (basic) | -0.05 | -0.04 | -0.16 | — | -0.36 | -0.37 | -0.36 | — |
| EPS (diluted) | -0.05 | -0.04 | -0.16 | — | -0.36 | -0.37 | -0.36 | — |
| Weighted avg. shares (diluted) | 65.44M | 54.63M | 37.35M | — | 11.59M | 5.55M | 4.90M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $7,879 | — | $26,582 | $34,006 | $31,318 | $123,445 | $196,248 | $73,194 |
| Receivables | $1.42M | $3.40M | $3.60M | $3.72M | $6.61M | $6.72M | $6.89M | $6.59M |
| Inventory | $155,917 | $563,370 | $593,375 | $1.62M | $959,706 | $1.55M | $2.03M | $2.02M |
| Current assets | $1.59M | $3.98M | $4.23M | $5.38M | $7.63M | $8.43M | $9.15M | $8.70M |
| PP&E, net | — | $619,907 | $649,079 | $4.11M | $4.45M | $4.80M | $5.10M | $5.43M |
| Intangibles | — | — | $3,416 | $95,144 | $98,144 | $101,144 | $104,144 | $107,144 |
| Total assets | $1.86M | $4.92M | $5.32M | $10.13M | $13.08M | $14.58M | $15.58M | $15.56M |
| Current liabilities | $11.64M | $11.11M | $10.39M | $11.98M | $12.86M | $13.72M | $12.85M | $12.42M |
| Total liabilities | $11.64M | $11.11M | $10.39M | $11.98M | $12.86M | $14.03M | $13.12M | $12.86M |
| Shareholders' equity | -$9.79M | -$6.75M | -$5.31M | -$1.86M | $219,602 | $554,887 | $2.45M | $2.70M |
| Shares outstanding | 70.12M | 61.87M | 44.80M | 32.75M | 26.25M | 5.70M | 5.38M | 2.83M |
| Cash flow statement | ||||||||
| Operating cash flow | $9,098 | -$131,067 | $216,850 | $151,438 | -$206,627 | -$343,173 | -$906,133 | -$526,470 |
| Capital expenditure | — | — | — | $0 | $0 | $0 | $15,000 | — |
| Free cash flow | — | — | — | $151,438 | -$206,627 | -$343,173 | -$921,133 | — |
| Investing cash flow | -$6,470 | — | — | $369 | $0 | $0 | -$85,000 | — |
| Financing cash flow | $5,251 | $108,208 | -$224,274 | -$149,119 | $114,500 | $270,370 | $1.11M | $565,193 |
| Depreciation & amortization | $0 | $29,172 | $314,435 | $347,034 | $348,224 | $345,804 | $346,887 | $346,512 |
| Stock-based compensation | $0 | $0 | $1.16M | $0 | $1.45M | $0 | $0 | $0 |
Free plan shows the latest 8 periods; Pro shows all 38 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.